{"id":39174,"date":"2017-05-19T07:10:37","date_gmt":"2017-05-19T11:10:37","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39174"},"modified":"2017-05-19T00:53:21","modified_gmt":"2017-05-19T04:53:21","slug":"novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174","title":{"rendered":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Novavax, Inc. (NASDAQ:NVAX)<\/strong> has announced its financial results for the first quarter of 2017. In a statement, Novavax President and CEO Stanley C. Erck said the company made a lot of progress in the implementation of key clinical studies of the RSV F vaccine for maternal immunization to infants as well as for use in adults. The company expected to report positive data from the adult trial in 90 days time.<\/p>\n<p style=\"text-align: justify;\">In addition, the company has announced holding talks with the FDA to undertake an informational analysis of the Prepare study which is aimed at establishing the level of efficacy of the vaccine.<\/p>\n<p style=\"text-align: justify;\">The company reported a net loss of (-$43.9) million or (-$0.16) per share in the first quarter compared to the (-$77.3) million or (-$0.29) per share reported in the first quarter of the previous financial year.<\/p>\n<p style=\"text-align: justify;\">The company\u2019s revenue in the quarter amounted to $5.7 million which is equivalent to 35% increase from the $4.2 that was reported in the same period in 2016. The increase is as a result of increase in revenue from the BMGF grant that was granted in relation to the ongoing Prepare clinical study.<\/p>\n<p style=\"text-align: justify;\">Research and development expenses amounted to $37.7 million, a 45% decrease from the $69 million that was reported in Q1 of 2016. The reduction is attributed to decrease in costs associated with clinical studies as well as development activities related to the RSV F Vaccine. The company also reported lower employee-related costs in the quarter.<\/p>\n<p style=\"text-align: justify;\">The company reported $8.9 million in general and administrative expenses in Q1 2017 representing a 16% decrease from the $10.5 million that was reported in Q1 2016. The decrease is attributed to reduced professional fees for pre-commercialization activities.<\/p>\n<p style=\"text-align: justify;\">The company reported $3 million in net interest income compared to $1.9 million that was reported in Q1 of 2016.<\/p>\n<p style=\"text-align: justify;\">At the close of the quarter, the company had $211.2 million in cash and cash equivalents compared to the $235.5 million that the company had at the close of the last financial year ended December 31, 2016. Net cash used in operating activities amounted to $38.6 million compared to $69.8 million in the same period of the previous financial year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novavax, Inc. (NASDAQ:NVAX) has announced its financial results for the first quarter of 2017. In a statement, Novavax President and CEO Stanley C. Erck said [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":39181,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[358,6461,7142,6460,12658],"stock_ticker":[],"class_list":["post-39174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaq","tag-nasdaqnvax","tag-novavax-inc","tag-novavax-inc-nasdaqnvax","tag-nvax","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Novavax, Inc. (NASDAQ:NVAX) has announced its financial results for the first quarter of 2017. In a statement, Novavax President and CEO Stanley C. Erck said [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-19T11:10:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017\",\"datePublished\":\"2017-05-19T11:10:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\"},\"wordCount\":353,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg\",\"keywords\":[\"NASDAQ\",\"NASDAQ:NVAX\",\"Novavax Inc.\",\"Novavax Inc. (NASDAQ:NVAX)\",\"NVAX\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\",\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg\",\"datePublished\":\"2017-05-19T11:10:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg\",\"width\":500,\"height\":333},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174","og_locale":"en_US","og_type":"article","og_title":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR","og_description":"Novavax, Inc. (NASDAQ:NVAX) has announced its financial results for the first quarter of 2017. In a statement, Novavax President and CEO Stanley C. Erck said [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-05-19T11:10:37+00:00","og_image":[{"width":500,"height":333,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017","datePublished":"2017-05-19T11:10:37+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174"},"wordCount":353,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg","keywords":["NASDAQ","NASDAQ:NVAX","Novavax Inc.","Novavax Inc. (NASDAQ:NVAX)","NVAX"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174","url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174","name":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg","datePublished":"2017-05-19T11:10:37+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39180-g130504b.jpg","width":500,"height":333},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-5-7-million-in-revenue-in-q1-2017-39174#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Novavax, Inc. (NASDAQ:NVAX) Reports $5.7 Million In Revenue In Q1 2017"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39174"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39174\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39181"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39174"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}